News

GTCR Completes Significant Sale of Antylia Scientific

GTCR Completes Significant Sale of Antylia Scientific

GTCR Completes Sale of Antylia Scientific

GTCR, a prominent player in the private equity landscape, has achieved a significant milestone by completing the sale of Antylia Scientific. This strategic move follows a decade of transformative growth under GTCR's leadership strategy, reinforcing the firm's commitment to partnering with management teams to unlock their full potential in the life sciences sector.

Transaction Details

The sale of Antylia Scientific to Brookfield Asset Management and CDPQ was finalized for an impressive valuation of approximately $1.34 billion. This deal underlines the remarkable progress Antylia has made in its core markets, which include biopharmaceuticals, clinical diagnostics, and environmental testing.

Antylia's Growth Journey

Antylia Scientific, previously known as Cole-Parmer Instrument Company, has undergone significant evolution since GTCR acquired the company in 2014 from Thermo Fisher Scientific. The firm has strategically invested substantial capital to augment Antylia's geographic footprint and broaden its suite of essential lab products, bioprocessing tools, and critical life science reagents. The company has successfully integrated 15 acquisitions that complement its core offerings, further enhancing its foothold in the life sciences market.

Success Stories

Notably, in late 2021, Antylia divested its Masterflex bioprocessing business segment for $2.9 billion to Avantor Inc. This strategic decision was pivotal, showcasing Antylia's ability to innovate and adapt to market demands, ultimately transforming its operations into a prime asset for supporting biologics and vaccine production.

Leadership Perspectives

Sean Cunningham, Managing Director and Head of Healthcare at GTCR, expressed pride in the transformation achieved through the partnership. He recognized the profound impact of Antylia's leadership and their collective efforts to drive success. Meanwhile, Dean Mihas, GTCR Co-CEO, acknowledged the unique position Antylia holds within the life sciences sector and conveyed confidence in the company's ongoing progress.

Future of Antylia Scientific

Looking ahead, Jonathan Salkin, CEO of Antylia, emphasized the collaborative spirit that has fueled the company's growth. He expressed gratitude for GTCR's support and shared excitement for the future of Antylia as it continues to innovate and lead in the life sciences industry.

Advisors' Role

Goldman Sachs and Jefferies played significant roles as financial advisors during this transaction, while Kirkland & Ellis provided legal counsel to Antylia, navigating the complexities involved in such a sizable deal.

About GTCR

Founded in 1980, GTCR has established itself as a leader in private equity, with a particular focus on transformative growth across various sectors, including Business & Consumer Services and Healthcare. Over its operational history, GTCR has invested more than $30 billion in over 280 companies, now overseeing more than $45 billion in equity capital. With offices in key markets, GTCR continues to seek opportunities that drive significant value creation.

About Antylia Scientific

Antylia Scientific is a notable player in the life sciences tools landscape, providing essential products to various sectors, including pharmaceuticals and environmental markets. The company's diverse portfolio features respected brands known for innovation in environmental testing and diagnostics. By offering cutting-edge solutions, Antylia remains committed to advancing scientific discovery and contributing to public health.

Frequently Asked Questions

What is the latest news about GTCR?

GTCR has successfully completed the sale of Antylia Scientific, marking a significant achievement in their strategic portfolio management.

How much was Antylia Scientific sold for?

Antylia Scientific was sold for approximately $1.34 billion as part of the deal with Brookfield Asset Management and CDPQ.

What industries does Antylia Scientific serve?

Antylia Scientific serves various markets, including biopharmaceuticals, clinical diagnostics, and environmental testing.

Who were the advisors involved in this transaction?

Goldman Sachs and Jefferies acted as financial advisors, while Kirkland & Ellis served as legal counsel for Antylia during the sale.

What is GTCR's investment strategy?

GTCR focuses on transformative growth by partnering with management leaders to build and enhance market-leading companies through strategic investments and acquisitions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sustainability 2026: Action Beyond Conference Halls

Updated Category News Views 104

Carbon-Neutral Promises: Walking the Walk Forget endless talk—Shanghai's 2026 Sustainability Global Leaders Conference hammered home that actions need to spill over beyond the plush conference seats every single attendee warmed. We're not talking about token efforts either; they ensured the gathering itself was carbon-neutral. That's practicing what you preach with a...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 105

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading
Jury Awards $29M in Landmark School Abuse Case

Updated Category News Views 86

California Schools Face Scrutiny Over Abuse Verdict Some days, the gavel falls, and its echo shakes up more than just a courtroom. That’s exactly what we’re seeing with this hefty $29 million verdict against ABC Unified School District. It’s not just a payout; it’s a bombshell that could change the landscape for how schools handle allegations of abuse. $29 Million...

Continue Reading
CorelDRAW PowerTRACE: Fast, Precise Vector Conversion

Updated Category News Views 43

Expert Consumers Spotlight CorelDRAW PowerTRACE Ah, the humble art of converting blurry bitmaps into crisp vectors—a task plenty have fumbled through with countless late nights and missed deadlines. But here's a kicker: CorelDRAW PowerTRACE seems to be setting new standards in bitmap-to-vector conversions this year, grabbing attention with some pretty spiffy upgrades...

Continue Reading
Ast?'s Strategy: Scaling Brands with Operator Insight

Updated Category News Views 44

Defining the Investor-Entrepreneur Partnership Ah, building a consumer brand is no walk in the park, but what about scaling it? Here's where the rubber really meets the road. Enter Ast? Consumer Partners, a firm that clearly understands that scaling a brand isn't all about throwing cash at it—it’s about precision and the right mix of wisdom, much like a seasoned chef...

Continue Reading
Key Life Events That Demand a Financial Plan Change

Updated Category News Views 39

Navigating Life's Milestones with Financial Savvy Nothing stirs the financial pot quite like life's big events. The grind of daily life might trick you into thinking everything's fine, but ignore these milestones at your peril. Ted Thatcher, a financial advisor from Roseville, California, lays it out in HelloNation's latest foray into sound financial planning: your...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 129

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading
GAC Hits Record with 223,000 Units Exported in 2026

Updated Category News Views 88

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

Continue Reading
Aries Ignites a Social Renaissance in La Jolla

Updated Category News Views 58

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

Continue Reading
'Dedicate' Series Arrives on Prime, Tapping Global Heartstrings

Updated Category News Views 102

An Unconventional Hit Finds a New Home Kick back for a second, because this ain't just another series buried under the deluge of shows streaming these days. Nope, this is about 'Dedicate,' a joint of its own unique flavor that's now nabbed a spot on Prime Video. It's not like we're talking about the latest Hollywood blockbuster here—it's a series brought to you by The...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Tesla's Market Dynamics Ahead of Earnings Reveal

Updated Category News Views 96

Understanding Tesla's Current Market Position Tesla Inc's stock, identified by the ticker TSLA, is approaching a critical moment with its third-quarter earnings expected to be announced after market hours on an upcoming Wednesday. Investors are keenly watching how the company's performance will unfold, especially given the notable price trends observed year-to-date....

Continue Reading
Dustin Bass Joins ENA Leadership in Strengthening Nursing Bonds

Updated Category News Views 89

Dustin Bass Begins His Journey as ENA President The 2026 president of the Emergency Nurses Association (ENA), Dustin Bass, is eager to embark on a significant year for emergency nursing. His passion revolves around uniting members of the ENA and fostering a sense of belonging within the emergency nursing community. With over 40,000 members, the ENA plays a crucial role in...

Continue Reading
New York Medicaid Embraces TMS Therapy for Depressive Disorders

Updated Category News Views 211

Expansion of TMS Therapy Coverage by New York Medicaid MALVERN, Pa. — Neuronetics, Inc. (NASDAQ: STIM), a prominent medical technology company dedicated to enhancing the quality of life for those with neurohealth disorders, has exciting news. The state of New York has decided to expand Medicaid coverage to include Transcranial Magnetic Stimulation (TMS) therapy for...

Continue Reading
Essential Financial Planning Tips for 2024

Updated Category Personal Finance Views 779

In an era marked by rapid technological advancements and unpredictable economic landscapes, financial planning has emerged as a crucial skill set, especially for Millennials, Gen Z, and young professionals. With 2024 on the horizon, understanding how to effectively manage your finances is more important than ever. This comprehensive guide will walk you through the...

Continue Reading
Understanding the Latest Developments in Neumora Therapeutics Lawsuit

Updated Category News Views 210

Leading the Charge: Neumora Therapeutics Investor Lawsuit Stockholders of Neumora Therapeutics, Inc. (NASDAQ: NMRA) are now facing a pivotal moment as a class action lawsuit emerges. With potential legal avenues for recourse, it’s essential for investors to be informed about their rights and what they need to do next. Understanding Class Action Lawsuits A class action...

Continue Reading